Skip to main content
H. Lundbeck A logo

H. Lundbeck A — Investor Relations & Filings

Ticker · HLUN ISIN · DK0061804770 LEI · 5493006R4KC2OI5D3470 CO Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2021-02-04 Director's Dealing
Country DK Denmark
Listing CO HLUN

About H. Lundbeck A

https://www.lundbeck.com/global

H. Lundbeck A/S is a global biopharmaceutical company specializing in brain diseases. The company is engaged in the research, development, manufacturing, and marketing of transformative therapies for a range of psychiatric and neurological disorders. Its portfolio and pipeline focus on conditions such as depression, mood disorders, and rare childhood-onset epilepsies. Lundbeck is dedicated to advancing neuroscience to improve the quality of life for individuals affected by central nervous system disorders.

Recent filings

Filing Released Lang Actions
Director's Dealing 2021
Director's Dealing Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and explicitly states it is disclosing "Ledende medarbejderes og deres nærtståendes transaktioner med aktier og tilknyttede værdipapirer i H. Lundbeck A/S" (Transactions in shares and related securities by senior employees and their closely associated persons). This content directly matches the definition of Director's Dealing (insider trades by executives). The specific code for this is DIRS.
2021-02-04 Danish
Director's Dealing 2021
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties' and details specific share transactions (vesting of Restricted Shares) by named executives (Jacob Tolstrup, Anders Götzsche, Lars Bang). This content directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2021-02-04 English
Annual Report 2020
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Lundbeck, containing a management review, performance outlook, strategic review, and detailed consolidated financial statements for the fiscal year 2020. It includes sections such as 'Management Review', 'Financial Statements', and '5 Years Performance', which are characteristic of a full Annual Report (10-K equivalent for non-US entities). It is not an announcement or a summary, but the full report itself. FY 2020
2021-02-04 English
Annual Report (ESEF) 2020
Annual Report (ESEF) Classification · 100% confidence FY 2020
2021-02-04 English
Annual Report 2020
Annual Report Classification · 100% confidence The document is a comprehensive financial report for the fiscal year 2020, containing detailed financial statements, management review, key figures, and forward-looking guidance. It is clearly a full annual report rather than a short announcement or a quarterly interim report, as it covers the full period from 1 January to 31 December 2020 and includes extensive management commentary and audited-style financial tables. FY 2020
2021-02-04 English
Audit Report / Information 2019
Audit Report / Information Classification · 95% confidence The document is explicitly titled "Adjusted Supplementary Information to the Annual Report 2019". This indicates it is supplementary data related to the main Annual Report (10-K). However, the definitions provided do not have a specific code for 'Adjusted Supplementary Information'. The document contains detailed financial statements (Income Statement, Balance Sheet, Cash Flow Statement) and extensive summary tables comparing 2018 and 2019 results, which are characteristic of a comprehensive financial report, not just a brief release (ER) or a general announcement (RPA/RNS). Since it is supplementary information to the Annual Report (10-K), and it contains the core financial statements and detailed notes, it is most closely aligned with the comprehensive reporting structure of an Annual Report (10-K) or an Interim Report (IR). Given the context of providing detailed financial statements and management commentary for a full fiscal year (2019), it functions as a detailed financial disclosure. If the document were the primary, unadjusted 10-K, the code would be 10-K. Since it is an *adjustment* to the Annual Report, it is still a comprehensive annual filing. In the absence of a specific 'Adjusted Annual Report' code, and given its length and depth (78k characters, containing full statements), it is classified as a comprehensive financial report. If we strictly follow the definitions: - It is not an ER (Earnings Release - too detailed). - It is not an IR (Interim Report - it covers the full year). - It is not an AR (Audit Report - it contains the financials themselves, not just the audit opinion). - It is not an RPA (Report Publication Announcement - it *is* the report content, not just an announcement of it). Therefore, the closest fit for a comprehensive, full-year financial disclosure document, even if adjusted, is the Annual Report category (10-K), as it serves the function of the annual filing. *Self-Correction/Refinement based on context:* While the document is supplementary, it contains the core financial statements and management sign-off for the year 2019, making it a primary component of the annual disclosure package. The 10-K is the standard SEC filing for this, but for non-US filers, this comprehensive annual document serves the same purpose. Given the options, 10-K is the best fit for a full-year financial report, even if this specific document is an 'Adjusted Supplementary' version thereof. FY 2019
2021-01-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.